Amie Scott

Amie Scott is a health outcomes researcher with 20 years of experience in real-world evidence (RWE), real-world data (RWD), and patient-reported outcomes (PRO). Currently a Director at Pfizer, Amie oversees the design and implementation of RWE studies and has authored or co-authored 44 peer-reviewed publications and 78 abstracts. Amie has previously held positions at SEAS Capital Partners, KMK Consulting, Memorial Sloan Kettering Cancer Center, and the University of British Columbia, contributing to significant advancements in research methodologies and data analysis. Alongside professional pursuits, Amie is completing a Master of Public Health in Epidemiology and Biostatistics at Columbia University and holds a BS in Molecular Biology from Trinity Western University.